Literature DB >> 33368849

Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic.

Simona Bonavita1,2, Maddalena Sparaco1, Antonio Russo1, Giovanna Borriello3, Luigi Lavorgna1.   

Abstract

BACKGROUND AND
PURPOSE: The COVID-19 emergency may cause post-traumatic stress disorder (PTSD), and with regard to people with MS (pwMS) chronic exposure to a wide range of challenging life events has been shown to be correlated with worsening of neurological symptoms, increased lesion burden on brain magnetic resonance imaging and relapses. The aim was to investigate perceived stress, depression, perceived social support, habits and behaviour changes in pwMS through COVID-19 in comparison to a control group.
METHODS: A web-based survey was posted on SMsocialnetwork.com to investigate perceived stress (using the Perceived Stress Scale), depression (with Patient Health Questionnaire 2) and perceived social support (using Social Provision Scale 10 item) in pwMS and a control group through the COVID-19 pandemic. A secondary group of people with migraine was investigated.
RESULTS: In all, 1286 answers from 612 pwMS and 674 control people were included in the final analysis. The answers from 318 people with migraine were included for a secondary analysis. A higher proportion of pwMS were depressed (43.1% vs. 23.1%; p < 0.001), had a high level of perceived stress (58% vs. 39.8%; p < 0.001) and felt significantly less social support (median 33 vs. 35; Q1-Q3 28-36 vs. 32-37; p < 0.001) compared to the control group. A higher percentage of people with migraine were depressed (50% vs. 43%, p = 0.04) compared to pwMS.
CONCLUSIONS: Considering the negative impact that prolonged stress may have on clinical and radiological disease activity of pwMS, and bearing in mind that a beneficial effect has been demonstrated and achieved with stress management, it is suggested to promote stress control in these patients during the COVID-19 pandemic.
© 2020 European Academy of Neurology.

Entities:  

Keywords:  COVID-19; multiple sclerosis; social support; stress; stress management

Year:  2020        PMID: 33368849     DOI: 10.1111/ene.14697

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  11 in total

1.  Social support as a mediator in the relationship between perceived stress and nomophobia: An Investigation among Malaysian university students during the COVID-19 pandemic.

Authors:  Samantha Arielle Lai; Khong Yun Pang; Ching Sin Siau; Caryn Mei Hsien Chan; Yee Kee Tan; Pei Boon Ooi; Mohamad Ikhram Bin Mohamad Ridzuan; Meng Chuan Ho
Journal:  Curr Psychol       Date:  2022-06-02

2.  "If You Can't Control the Wind, Adjust Your Sail": Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study.

Authors:  Silvia Poli; Michela Rimondini; Alberto Gajofatto; Maria Angela Mazzi; Isolde Martina Busch; Francesca Gobbin; Federico Schena; Lidia Del Piccolo; Valeria Donisi
Journal:  Int J Environ Res Public Health       Date:  2021-04-14       Impact factor: 3.390

3.  Patterns of Psychological Responses among the Public during the Early Phase of COVID-19: A Cross-Regional Analysis.

Authors:  Yuen Yu Chong; Wai Tong Chien; Ho Yu Cheng; Demetris Lamnisos; Jeļena Ļubenko; Giovambattista Presti; Valeria Squatrito; Marios Constantinou; Christiana Nicolaou; Savvas Papacostas; Gökçen Aydin; Francisco J Ruiz; Maria B Garcia-Martin; Diana P Obando-Posada; Miguel A Segura-Vargas; Vasilis S Vasiliou; Louise McHugh; Stefan Höfer; Adriana Baban; David Dias Neto; Ana Nunes da Silva; Jean-Louis Monestès; Javier Alvarez-Galvez; Marisa Paez Blarrina; Francisco Montesinos; Sonsoles Valdivia Salas; Dorottya Őri; Bartosz Kleszcz; Raimo Lappalainen; Iva Ivanović; David Gosar; Frederick Dionne; Rhonda M Merwin; Andrew T Gloster; Maria Karekla; Angelos P Kassianos
Journal:  Int J Environ Res Public Health       Date:  2021-04-14       Impact factor: 3.390

Review 4.  Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.

Authors:  Amin Zarghami; Mohammad A Hussain; Julie A Campbell; Chigozie Ezegbe; Ingrid van der Mei; Bruce V Taylor; Suzi B Claflin
Journal:  Mult Scler Relat Disord       Date:  2022-01-25       Impact factor: 4.808

5.  Impact of COVID-19 lockdown on progressive multiple sclerosis patients.

Authors:  Marco Vercellino; Chiara Bosa; Anastasia Alteno; Valentina Schillaci; Manuel Petracca; Stella Marasciulo; Paola Cavalla
Journal:  Neurol Sci       Date:  2022-01-24       Impact factor: 3.830

6.  A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.

Authors:  Marina Boziki; Charis Styliadis; Christos Bakirtzis; Eleni Grigoriadou; Aggeliki-Styliani Sintila; Ioannis Nikolaidis; Aliki Vrienniou; Lotte Geys; Sygkliti-Henrietta Pelidou; Lesley Probert; Georgios Papazisis; Panagiotis Bamidis; Nikolaos Grigoriadis
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

7.  The impact of the COVID-19 pandemic on physical therapy practice for people with multiple sclerosis: A multicenter survey study of the RIMS network.

Authors:  Turhan Kahraman; Kamila Rasova; Johanna Jonsdottir; Carme Santoyo Medina; Daphne Kos; Susan Coote; Andrea Tacchino; Tori Smedal; Ellen Christin Arntzen; Gillian Quinn; Yvonne Learmonth; Ludovico Pedulla; Lousin Moumdjian; Alon Kalron
Journal:  Mult Scler Relat Disord       Date:  2022-04-10       Impact factor: 4.808

8.  Mental Health Status of People with Multiple Sclerosis during the COVID-19 Pandemic.

Authors:  Maciej Wilski; Magdalena Koper; Jarosław Gabryelski; Waldemar Brola; Tomasz Tasiemski
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

Review 9.  Telemedicine application to headache: a critical review.

Authors:  Emanuele Spina; Gioacchino Tedeschi; Antonio Russo; Francesca Trojsi; Rosa Iodice; Stefano Tozza; Aniello Iovino; Francesco Iodice; Gianmarco Abbadessa; Francesco di Lorenzo; Giuseppina Miele; Elisabetta Maida; Giovanni Cerullo; Maddalena Sparaco; Marcello Silvestro; Letizia Leocani; Simona Bonavita; Fiore Manganelli; Luigi Lavorgna
Journal:  Neurol Sci       Date:  2022-01-24       Impact factor: 3.830

10.  COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Authors:  Masoud Etemadifar; Nahad Sedaghat; Ali Aghababaee; Parisa K Kargaran; Mohammad Reza Maracy; Mazdak Ganjalikhani-Hakemi; Milad Rayani; Amir Parsa Abhari; Reza Khorvash; Mehri Salari; Hosein Nouri
Journal:  Mult Scler Relat Disord       Date:  2021-03-20       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.